Soft tissue sarcoma - Treatment with radium-224 Factor
Last reviewed for CCPS 20 August 2008.
Preliminary questions [30648]
30651 [1] there is some evidence that treatment with radium-224 may be a factor in the development of the condition under consideration.
30652 [1] the veteran has received treatment with radium-224 at some time.
30656 [2] the veteran received treatment with radium-224 as treatment for an illness or injury which is identifiable. 30653 — the veteran has established the causal connection between receiving treatment with radium-224 and VEA service for the clinical onset of soft tissue sarcoma. 30650 — the veteran has established the causal connection between receiving treatment with radium-224 and eligible service for the clinical onset of soft tissue sarcoma. or 30649 — the veteran has established the causal connection between receiving treatment with radium-224 and operational service for the clinical onset of soft tissue sarcoma. Clinical onset and operational service [30649] 30659 — the identified illness or injury for which treatment with radium-224 was received is causally related to operational service. [4] [5] Clinical onset and eligible service [30650]
30660 — the identified illness or injury for which treatment with radium-224 was received is causally related to eligible service. [8] [5]
Links
[1] https://clik.dva.gov.au/ccpsb009rc-18
[2] clikpopup://CCPS/Treatment with radium-224 for illness or injury which is identifiable
[3] clikpopup://CCPS/reject30656No
[4] clikpopup://CCPS/reject30657No
[5] clikpopup://CCPS/reject30659,30660No
[6] clikpopup://CCPS/Treatment with radium-224 as treatment for illness or injury at least five years before the clinical onset of the condition under consideration
[7] clikpopup://CCPS/reject30658No
[8] clikpopup://CCPS/reject30660No